Research Use Only — Not for Human Consumption. This compound is sold exclusively for in vitro laboratory research by qualified professionals.
CJC-1295
GHRH Analogue with DAC
CJC-1295 is a tetrasubstituted analogue of Growth Hormone Releasing Hormone (GHRH) incorporating a Drug Affinity Complex (DAC) that enables covalent binding to endogenous serum albumin, extending circulating half-life from minutes to approximately 6–8 days. The compound retains high affinity for the GHRH receptor and produces sustained, pulsatile growth hormone secretion in pituitary research models. For research use only — not for human consumption.
Third-Party Tested. Every Lot.
Every batch of CJC-1295 undergoes independent HPLC and mass spectrometry analysis through an accredited third-party laboratory before it is released for sale. No exceptions. No internal-only certificates.
RP-HPLC Analysis
Every lot measured by reverse-phase HPLC. CJC-1295 consistently achieves 99.1%+ purity across batches.
ESI Mass Spec
Electrospray ionization mass spectrometry confirms exact molecular weight and rules out structural isomers or impurities.
Lot-Specific CoA
Your Certificate of Analysis references your exact lot number with actual chromatogram data — not a generic template.
Theoretical Research Analysis
All research information below reflects published preclinical literature only. This product is not for human use, consumption, or clinical application of any kind.
CJC-1295 with DAC has become a standard tool in neuroendocrine research due to its uniquely extended activity profile, allowing chronic GHRH receptor stimulation studies without frequent re-administration.
Sequence Information
Amino acid sequence:
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys(DAC)-Val-Leu...Molecular Formula
C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight
3367.97 g/mol
You May Also Like
View allIpamorelin
Selective GH Secretagogue
Testagen 20 mg
Testagen — Thymic Tetrapeptide
Tesamorelin 10mg
Tesamorelin — GHRH(1-44) Analogue
FRAG 176-191
HGH Fragment 176–191 — 5 mg